Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

Research Library

ARA-290 research

6 articles to explore, with links to 7 original sources.

About ARA-290

ARA-290, also known as cibinetide, is an eleven-residue peptide used in cellular signaling research.

Understand the science

  • How a folded protein inspired an eleven-amino-acid peptide

    ARA-290, also called cibinetide, is an 11-amino-acid example derived from the shape of erythropoietin. A foundational 2008 study asked whether part of that protein's surface could reproduce certain tissue responses while leaving red-blood-cell production unstimulated in the experiments.

    1 source (2008)

Explore study findings

  • What a 2026 retraction changed about kidney research

    ARA-290, also called cibinetide or pyroglutamate helix B surface peptide, is an 11-amino-acid experimental peptide designed from the shape of erythropoietin. A February 2026 journal notice changed how researchers should read one older study of the peptide in an animal model of acute kidney injury.

    2 sources (2008, 2026)

  • Why a sarcoidosis trial photographed nerves in the cornea

    ARA-290, or cibinetide, is a synthetic 11-amino-acid peptide designed to engage a proposed tissue-protection signaling pathway. Researchers studying small nerve fibers in sarcoidosis needed a way to measure tissue changes in living people.

    2 sources (2017, 2026)

  • What the eye study found beyond a nerve image

    ARA-290, called cibinetide in a 2020 eye study, is an 11-amino-acid peptide designed from erythropoietin. That older phase 2 pilot asked whether the peptide would affect diabetic macular edema, in which fluid accumulates in the central retina.

    2 sources (2017, 2020)

Check methods and identity

  • What a diabetic mouse wound model could measure

    ARA-290, also known as cibinetide, is a designed 11-amino-acid peptide modeled on a surface of erythropoietin. An older laboratory study, first published online in 2017, investigated how wounds in mice with genetic diabetes responded to the peptide.

    1 source (2017)

Interpret the evidence

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice.